Electrocatalytically Amplified Immunosensing Enabled by Titanium Oxynitride‐Supported Ru Nanodots on Graphene Oxide Hybrid Architecture
Small · 2026
DOI: 10.1002/smll.74840 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2026. Verfasst von Mitja Koderman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Analytical Chemistry, National Institute of Chemistry, Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Graphite, Titanium, Ruthenium, Biosensing Techniques. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Slovenian Research and Innovation Agency, Research Projects, Young Researcher Contract.
Abstract (Originalsprache)
Electrocatalytically amplified electrochemical immunosensing is a powerful strategy for sensitive and interference‐free detection of biomarkers. Herein, we report a high‐performance electrochemical immunosensor enabled by a hierarchical hybrid architecture comprising Ru nanodots anchored on titanium oxynitride nanoflakes dispersed on graphene oxide (Ru/TiON‐GO), linked via APTES to biorecognition building blocks. The engineered heterostructure exhibits advanced electrocatalytic activity, arising from synergistic electronic coupling between Ru nanodots and the highly conductive TiON‐GO support, effectively promoting interfacial electron transport between the electrocatalytic surface and the [Fe(CN) 6 ] 3−/4− redox probe. Leveraging this electrocatalytic platform, a prostate‐specific antigen (PSA) impedimetric immunosensor was constructed, achieving a limit of detection of 0.06 ng mL −1 (2.3 pM) and a wide linear response covering clinically relevant concentration range. The immunosensor demonstrates excellent selectivity in human serum, operating in interference‐free mode even in the presence of common coexisting biomolecules, highlighting suitability for medical diagnostics. Density functional theory calculations further elucidate the origin of the enhanced electrocatalytic performance, with charge density difference plots and density of states analysis revealing Ru‐driven electron redistribution and increased density of states near the Fermi level. This work establishes the Ru/TiON‐GO nanocomposite as a robust electrocatalytic platform for advanced immunosensing applications, paving the way toward next‐generation electrochemical diagnostic devices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Analytical Chemistry, National Institute of Chemistry, Ljubljana, Slovenia.
- Faculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia.
- Department of Materials Chemistry, National Institute of Chemistry, Ljubljana, Slovenia.
ORCID-Profile: Milutin Smiljanić, Nejc Hodnik, Mitja Kolar, Nikola Tasić
Förderung
- The Slovenian Research and Innovation Agency
- Research Projects
- Young Researcher Contract
- Upgrading National Research Infrastructures-RIUM
- Ministry of Education, Science and Sport
- Ministrstvo za Izobraževanje, Znanost in Šport
Zitieren
APA
Koderman, M., Smiljanić, M., Cernatič, F., Bele, M., Ruiz-Zepeda, F., Hodnik, N., Kolar, M., Hočevar, S. B., & Tasić, N. (2026). Electrocatalytically Amplified Immunosensing Enabled by Titanium Oxynitride‐Supported Ru Nanodots on Graphene Oxide Hybrid Architecture. Small. https://doi.org/10.1002/smll.74840
Vancouver
Koderman M, Smiljanić M, Cernatič F, Bele M, Ruiz-Zepeda F, Hodnik N, et al. Electrocatalytically Amplified Immunosensing Enabled by Titanium Oxynitride‐Supported Ru Nanodots on Graphene Oxide Hybrid Architecture. Small. 2026. doi:10.1002/smll.74840
BibTeX
@article{Koderman2026,
author = {Koderman, Mitja and Smiljanić, Milutin and Cernatič, Filip and Bele, Marjan and Ruiz-Zepeda, Francisco and Hodnik, Nejc and Kolar, Mitja and Hočevar, Samo B and Tasić, Nikola},
title = {Electrocatalytically Amplified Immunosensing Enabled by Titanium Oxynitride‐Supported Ru Nanodots on Graphene Oxide Hybrid Architecture},
journal = {Small},
year = {2026},
doi = {10.1002/smll.74840}
}
EUVIMED